|
RPAP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18309999999922E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.419100E-04 |
| Normal-vs-Stage2 |
8.982900E-03 |
| Normal-vs-Stage3 |
1.644680E-04 |
| Normal-vs-Stage4 |
5.50389999999235E-05 |
| Stage1-vs-Stage2 |
8.092200E-01 |
| Stage1-vs-Stage3 |
3.643200E-01 |
| Stage1-vs-Stage4 |
1.419630E-01 |
| Stage2-vs-Stage3 |
7.056800E-01 |
| Stage2-vs-Stage4 |
3.449600E-01 |
| Stage3-vs-Stage4 |
4.856600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11849999999636E-05 |
| Normal-vs-AfricanAmerican |
9.318400E-02 |
| Normal-vs-Asian |
8.214400E-04 |
| Caucasian-vs-AfricanAmerican |
4.199600E-01 |
| Caucasian-vs-Asian |
7.892600E-01 |
| AfricanAmerican-vs-Asian |
3.209600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.54420000000522E-05 |
| Normal-vs-Female |
2.588800E-04 |
| Male-vs-Female |
1.016000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.553200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.55250000000762E-05 |
| Normal-vs-Age(61-80Yrs) |
4.048600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.040000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.976000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.913800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.001800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.741800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.140000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.010800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.158600E-01 |
| Classical-VS-Follicular |
6.098200E-02 |
| Classical-VS-Other |
1.320580E-01 |
| Classical-VS-Normal |
5.141900E-03 |
| Tall-VS-Follicular |
7.526200E-01 |
| Tall-VS-Other |
3.452200E-01 |
| Tall-VS-Normal |
3.340900E-03 |
| Follicular-VS-Other |
5.143200E-01 |
| Follicular-VS-Normal |
1.586980E-04 |
| Other-VS-Normal |
6.755300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43460000000084E-05 |
| Normal-vs-N1 |
1.53169999999037E-05 |
| N0-vs-N1 |
1.312640E-01 |
|
|
